Source:http://linkedlifedata.com/resource/pubmed/id/12798164
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0032105,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0037813,
umls-concept:C0205164,
umls-concept:C0205177,
umls-concept:C0302908,
umls-concept:C0449432,
umls-concept:C0680730,
umls-concept:C0870883,
umls-concept:C1148554,
umls-concept:C1179435,
umls-concept:C1524073,
umls-concept:C1548799,
umls-concept:C1610936,
umls-concept:C1705248
|
pubmed:issue |
1-2
|
pubmed:dateCreated |
2003-6-11
|
pubmed:abstractText |
The rapid, selective and sensitive liquid chromatographic-ion trap mass spectrometric (LC-MS(n)) method was developed and validated for determination of three major components (isovaleryspiramycins, ISV-SPMs) of a novel macrolide antibiotic bitespiramycin and their major active metabolites (spiramycins, SPMs) in rat plasma. The analytes ISV-SPMs, SPMs, internal standard roxithromycin and azithromycin were extracted from plasma samples by liquid-liquid extraction, and chromatographed on a C(18) column using two mobile phase systems. Detection was carried out on an ion trap mass spectrometer by selected reaction monitoring (SRM) mode via electrospray ionization (ESI). Three components (ISV-SPM I, II, III or SPM I, II, III) could be simultaneously determined within 6.5 min. Linear calibration curves were obtained in the concentration ranges of 4-200 ng/ml for ISV-SPM I and SPM I, 12-600 ng/ml for ISV-SPM II and SPM II, and 18-900 ng/ml for ISV-SPM III and SPM III. The intra- and inter-run precision (RSD), calculated from quality control (QC) samples were less than 8.8 and 10.4% for ISV-SPMs, and 9.3 and 11.2% for SPMs, respectively. The method was applied for the evaluation of the pharmacokinetics of bitespiramycin in rats following peroral/intravenous administration.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1570-0232
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
5
|
pubmed:volume |
791
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
45-53
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12798164-Animals,
pubmed-meshheading:12798164-Anti-Infective Agents,
pubmed-meshheading:12798164-Calibration,
pubmed-meshheading:12798164-Chromatography, Liquid,
pubmed-meshheading:12798164-Rats,
pubmed-meshheading:12798164-Reproducibility of Results,
pubmed-meshheading:12798164-Sensitivity and Specificity,
pubmed-meshheading:12798164-Spectrometry, Mass, Electrospray Ionization,
pubmed-meshheading:12798164-Spiramycin
|
pubmed:year |
2003
|
pubmed:articleTitle |
Determination of three major components of bitespiramycin and their major active metabolites in rat plasma by liquid chromatography-ion trap mass spectrometry.
|
pubmed:affiliation |
Laboratory of Drug Metabolism and Pharmacokinetics, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, PR China. zhongdf@china.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|